Transdermal drug delivery - A review

International Journal of Research in Pharmaceutical Sciences

Volumn 3, Issue 3, 2012, Pages 379-388

  Gandhi, Kamal ^a   Dahiya, Anu ^a   Monika, ^a   Kalra, Taruna ^a   Singh, Khushboo ^a  

^a Ram Gopal College of Pharmacy   (India)

Author keywords

Electroporation; Iontophoresis; Microneedles; Microporation; Percutaneous permeation; Sonophoresis; Transcutaneous permeation; Transdermal drug delivery

Indexed keywords

CLONIDINE; DRUG CARRIER; ESTRADIOL; FENTANYL; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NICOTINE; SCOPOLAMINE; TESTOSTERONE; TULOBUTEROL;

ANGINA PECTORIS; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; HORMONE SUBSTITUTION; HUMAN; PAIN; PARKINSON DISEASE; REVIEW; SKIN PERMEABILITY; SMOKING CESSATION; SUSTAINED DRUG RELEASE; SYSTEMIC CIRCULATION; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH;

EID: 84864615257     PISSN: 09757538     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Adgraft, J. 'Modulation of the barrier function of the skin', Skin Pharmacol Appl Skin Physiol, vol. 14, 2001 pp. 72-81.
2. Bagyalakshmi, J. Vamsikrishna, RP. Manavalan, R. Ravi, TK. Manna, PK. AAPS Pharm Sci Tech, 2007, Article7.
3. Baichwal, MR. 'Polymer films as drug delivery systems', Advances in drug delivery systems Bombay MSR foundation 1985, pp. 136-147.
4. Barry, BW. 'Lipid-proteinpartititioning theory of skin penetration enhancement', J. Control. Release, vol. 15, 1991, 237-248.
5. Barry, BW. Properties that Influence Percutaneous Absorption, 3rd ed, New York: Marcel Dekker, Inc, 1983.
6. Bora, P. Kumar, L. Bansal, KA. 'Review Article-Microneedle Technology For Advanced Drug Delivery: Evolving Vistas', CRIPS, vol. 9, no, 1, 2008 pp. 7-10.
7. Brown, L. Langer, R. 'Transdermal delivery of drugs', Ann Rev Med, vol. 39, 1988 pp. 221-9.
8. Calhoun, A. 'Recent Advances in Neonatal Pharmacotherapy: Transdermal Therapy in Neonates', Ann. Pharmacother, vol. 40, no. 4, 2006 pp. 710-719.
9. Chandrashekar, NS. Shobharani, RH. 'Physicochemical and Pharmacokinetic Parameters in drug selection and loading for transdermal drug delivery', Indian Journal of Pharmaceutical Sciences, vol. 70, no, 1, 2008 pp. 94-96.
10. Flynn, GL. Percutaneous Absorption, 3rd ed. New York: Marcel Dekker Inc, 1985.
11. Gondaliya, D. Pundarikakshudu, K. AAPS Pharm Sci Tech, 2003, Article3.
12. Gros, L. Clark, WE.' The structure of skin. In: Le G & Clark WE, editors: The tissue of the body, London: ELBS and Oxford University Press, 1980. pp. 299-313.
13. Guy, RH. Hadgraft, J. Bucks, DAW. 'Transdermal drug delivery and cutaneous metabolism', Xenobiotica, vol. 17, 1987 pp. 325-346.
14. Hadgraft, J. Guy, RH. Transdermal Drug Delivery, 2nd ed, New York: Marcel Dekker Inc, 1989.
15. Helier, J. Trescony, PV. 'Controlled drug release by polymer dissolution II, Enzyme mediated delivery device', J. Pharm. Sci, vol. 68, 1979 pp. 919. http://berkeley.edu/news/media/releases/2007/02/12 IRE.shtml. [Cited 2010 July 28]. http://www.permegear.com [Cited 2010 July 28]. http://www.theiaforum.org/april2004.html [Cited 2010 July 28].
16. Jacob, SW. Francone, CA. Structure and Function of Man, 2nd ed, Philadelphia: W.B. Saunders Co, 1970
17. Jain, N. K. 'Controlled and Novel Drug Delivery', CBS Publishers, and Distributors, 2002, 107.
18. Karim, A. 'Transdermal absorption: a unique opportunity for constant delivery of Nitroglycerin', Drug Dev Ind Pharm, vol. 9, 1983 pp. 671.
19. Keith, AD. Polymer matrix consideration for Transdermal Devices, Drug Dev Ind Pharm, vol. 9, 1983 pp. 605-625.
20. Ko, CU. 'Effect of skin penetration enhancers in transdermal drug delivery adhesives on skin adhesion and irritation, Proceed', Intern. Symp. Control. Rel. Bioact. Mater, vol. 23, 1996 pp. 281-282.
21. Kumar, R. Philip, A. 'Modified Transdermal Technologies: Breaking the Barriers of Drug Permeation via the Skin', Trop J Pharm Res, vol. 6, no. 1, 2007 pp. 633-644.
22. Kumar, TS. Selvam, RP Singh AK. 'Transdermal drug delivery systems for antihypertensive drugs', Int. J. Pharm. Biomed. Res, vol. 1, no. 1, 2010 pp. 1-8
23. Langer, Robert. 'Transdermal Drug Delivery: past progress: current status and future prospect', Advanced Drug Delivery Reviews, (2004) pp. 557-558.
24. Lee, M. Phillips, J. 'Transdermal patches: high risk for error?', Drug Top, 2002 pp. 54-55.
25. Merkle, HP. 'Transdermal delivery systems: Methods Find Exp Clin', Pharmacol, vol.11, 1989 pp. 135-53.
26. Miller II KJ, Govil SK, Bhatia KS, inventors; Mylan Pharmaceuticals, Inc., assignee; Fentanyl suspension based silicone adhesive formulations and devices for transdermal delivery of fentanyl. US Patent 7556823, 2009.
27. Neumann, E. Schaefer-Ridder, M. Wang, Y. Hofschneider, PH. 'Gene transfer into mouse lyoma cells by electroporation in high electric fields'. Emboj, vol. 1, no. 7, 1982 pp. 841-45.
28. Nitti, W. Sanders, Steven, Staskin, R. Dmochowski R. 'Transdermal Delivery of drugs for urologic applications', Basic Principles and Applications', Urology, Vol. 67, 2006 pp. 657-664.
29. Potts, RO. Lobo, RA.'Transdermal drug delivery:clinical considerations for the obstetrician gynecologist', Obstet Gynecol, vol. 105, 2005 pp. 953-61.
30. Qvist, MH. Hoeck, U. Kreilgaard, B. Madsen, F. Frokjaer, S. 'Release of chemical penetration enhancers from druginadhesive transdermal patches', Int. J. Pharm, vol. 231, 2002 pp. 253-263.
31. Rochazka, AV. 'New developments in smoking cessation', Chest, vol. 117, no. 4, 2000 pp. 169-175.
32. Samanta, MK. Dube, R. Suresh, B. Drug delivery Ind Pharm, vol.29, 2003, pp. 405-415.
33. Samisoe, G. 'Transdermal hormone therapy: gels and patches', Climacteric, vol. 7, 2004 pp. 347-56.
34. Siewert, M. Dressman, J. Brown, CK. Shah, VP. AAPS Pharm Tech, 2003, Article 7.
35. Singh, Somnath. (2005). 'An Overview of Transdermal Drug Delivery Industry Overview and Deals. Drug Delivery Report Autumn/Winter 2005, pp, 35-40, Available at http://www.drugdeliveryreport.com/articles/ddr_w2005_article06.pdf, (Accessed on 11/18/2008).
36. Stevenson, JC. 'Optimising delivery systems for HRT', Maturitas, vol. 33, 1999 pp. S31-8.
37. Sugar, IP. Neumann, E. 'Stochastic model for electric fieldinduced membrane pores Electroporation', Biophys Chem, vol.19, no. 3 1984, pp. 211-25.
38. Sugibayashi, K. Morimoto, Y. 'Polymers for transdermal drug delivery systems', Journal of Controlled Release, vol. 29, 1994 pp. 177-185.
39. Tyle, P. Drug Delivery device, 3rd edition, New York and Basel: Marcel Dekker, 2003.
40. Verma, PRP. Lyer, SS. Drug Dev Ind Pharm, vol.26, 2000, pp. 471-476.
41. Weiner, E. Victor, A. Johansson, ED. 'Plasma levels of d-Norgestel after oral administration', Contraception, vol. 14, 1976 pp. 563-570.
42. Williams, AC Barry, BW. 'Penetration enhancers', Adv. Drug Delivery Reviews, Vol. 56, 2004 pp. 603-618.
43. Williams, Adrian. 'Transdermal and Topical Drug Delivery Published by Pharmaceutical Press, 2003, pp. 14-18. www.pharmainfo.net (Accessed on 11/18/2008).